IONIQ Sciences announces Aaron B. Dorny has joined its Board of Directors
IONIQ Sciences Announces the Appointment of Aaron B. Dorny to its Board of Directors. […]
IONIQ Sciences Announces the Appointment of Aaron B. Dorny to its Board of Directors. […]
Biomerieux, which includes US-based BioFire, announced Q3 sales growth at 11.6%, significantly above expectations due, in part, to a strong upturn in US respiratory panels demand. […]
SpermQT analyzes the molecular function of sperm and is 6x more predictive of fertility potential than standard semen analysis. […]
Utah Business is proud to present its annual 40 Under 40 event that will be held in February 2022. […]
BioUtah member Discgenics Chairman and CEO Flagg Flanagan Among 100 Most Intriguing Entrepreneurs at 2021 Builders + Innovators Summit. […]
The BioHive Summit, powered in partnership with BioUtah, on Nov. 12 will live stream a distinguished line-up of speakers and panelists from inside and outside Utah’s burgeoning life sciences industry. […]
Join WTC Utah in Dubai, UAE for the largest U.S. government-led trade mission and business development forum. […]
Grants Totaling Over $3M Earmarked for Life Saving Medical Technology to Combat Massive Blood Loss […]
A clinical stage ophthalmology company, iVeena is developing disease-modifying therapeutics for a rare corneal disorder and an increasingly common form of nearsightedness […]
Yesterday, US Rep. Blake Moore (R-UT-1) visited the burgeoning BioHive community in Logan, touring Utah State University’s (USU0 state-of-the-art BioInnovations Center, Quansys Biosciences and ELITech. Utah’s life sciences industry, from Logan to St. George, is one of the fastest-growing in the nation. “Cache Valley has become a hub for bioscience, and I thank BioUtah for […]
SALT LAKE CITY, Oct. 7, 2021 /PRNewswire/ — PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today provided an update regarding its Investigational New Drug Application (IND) for SkinTE® with a proposed indication for chronic cutaneous ulcers submitted to the Food and Drug Administration (FDA) in July 2021. The Company received […]
NEW YORK and SALT LAKE CITY, Oct. 07, 2021 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the expansion of its commercial strategy to address early-stage kidney disease in the Veterans Health Administration patient population with the appointment of Jed Fulk to the position of Vice President Sales, Government Accounts. Mr. Fulk […]